Skip to main content
Opens in new window
NHS Wales
NHS 111 Wales
Skip Navigation
Accessibility
Contact us
Cymraeg
Cymraeg
All...
Search
All Wales Therapeutics and Toxicology Centre
Search
Cymraeg
Cymraeg
Menu
Home
Accessing medicines
Show Submenu For Accessing medicines
Medicine recommendations
Access to medicines in Wales
Make a submission
Medicines optimisation and safety
Show Submenu For Medicines optimisation and safety
Medicines optimisation guidance, resources and data
Yellow Card Centre Wales
Welsh National Poisons Unit
Work in progress
News, meetings and events
Show Submenu For News, meetings and events
News
Meetings
Events
About us
Show Submenu For About us
Who we are
What we do
Our committees
Who we work with
Our research
Our reports and strategies
Sustainability
Contact us
More
×
NHS Wales
NHS 111 Wales
Accessibility
Contact us
All...
Search
Listen
Home
›
Files
›
Appraisals - ASAR & FAR
Appraisals - ASAR & FAR
20/09/2024
Evidence Status Report: galsulfase (Naglazyme)155
20/09/2024
Evidence Status Report: miglustat 371
20/09/2024
Equality and Health Impact Assessment: miglustat 371
20/09/2024
Equality and Health Impact Assessment: galsulfase 155
10/07/2024
Final Recommendation: cytisine 3708
26/06/2024
Evidence Summary Report: cytisine 3708
26/06/2024
Equality and Health Impact Assessment : cytisine 3708
16/05/2024
Final Recommendation: opicapone (Ongentys) 5285
01/02/2021
Appraisal Report: opicapone (Ongentys) 911
01/05/2024
Appraisal Report: opicapone (Ongentys®) 5285
29/04/2024
Final Recommendation: trifarotene (Aklief) 3153 FAR
29/04/2024
Appraisal Report: trifarotene (Aklief) 3153
02/05/2024
Evidence summary report alglucosidase alfa (Myozyme)
03/04/2024
Equality Impact Assessment: trifarotene (Aklief) 3153
18/07/2023
Appraisal report: emtricitabine/tenofovir alafenamide (Descovy®) 2566
18/05/2023
Safety alert for dexmedetomidine (AWTTC Ref 661)
15/05/2023
Equality Impact Assessment levodopa carbidopa entacapone
27/04/2023
Final Recommendation: levodopa carbidopa entacapone (Lecigon) 4871
06/04/2023
Appraisal Report: levodopa carbidopa entacapone (Lecigon) 4871
08/08/2019
Final Recommendation: tenofovir (Viread) 1880
1
2
3
4
5
6
7
8
9
10
11
Follow AWTTC: